Metlife Inc (MET) Beta Value: Understanding the Market Risk

The price-to-earnings ratio for Metlife Inc (NYSE: MET) is above average at 37.96x. The 36-month beta value for MET is also noteworthy at 1.04. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 3 rating it as “overweight,” 6 rating it as “hold,” and 0 rating it as “sell.”

The public float for MET is 604.09M, and at present, short sellers hold a 1.22% of that float. The average trading volume of MET on April 16, 2024 was 3.57M shares.

MET) stock’s latest price update

The stock of Metlife Inc (NYSE: MET) has decreased by -1.00 when compared to last closing price of 70.14. Despite this, the company has experienced a -5.88% fall in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-12 that MetLife’s (MET) Connected Benefits aims to cater to the rising demand for a holistic employee benefits experience, enhancing employee satisfaction and productivity as a result.

MET’s Market Performance

Metlife Inc (MET) has experienced a -5.88% fall in stock performance for the past week, with a -3.42% drop in the past month, and a 0.89% rise in the past quarter. The volatility ratio for the week is 2.36%, and the volatility levels for the past 30 days are at 1.57% for MET. The simple moving average for the last 20 days is -4.73% for MET stock, with a simple moving average of 6.73% for the last 200 days.

Analysts’ Opinion of MET

Many brokerage firms have already submitted their reports for MET stocks, with Goldman repeating the rating for MET by listing it as a “Buy.” The predicted price for MET in the upcoming period, according to Goldman is $80 based on the research report published on January 08, 2024 of the current year 2024.

Barclays, on the other hand, stated in their research note that they expect to see MET reach a price target of $71. The rating they have provided for MET stocks is “Overweight” according to the report published on November 17th, 2023.

Deutsche Bank gave a rating of “Hold” to MET, setting the target price at $71 in the report published on October 05th of the previous year.

MET Trading at -1.62% from the 50-Day Moving Average

After a stumble in the market that brought MET to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -7.01% of loss for the given period.

Volatility was left at 1.57%, however, over the last 30 days, the volatility rate increased by 2.36%, as shares sank -4.08% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +6.26% upper at present.

During the last 5 trading sessions, MET fell by -5.88%, which changed the moving average for the period of 200-days by +26.55% in comparison to the 20-day moving average, which settled at $72.74. In addition, Metlife Inc saw 5.01% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at MET starting from PAPPAS BILL, who sale 27,000 shares at the price of $72.27 back on Mar 18 ’24. After this action, PAPPAS BILL now owns 57,768 shares of Metlife Inc, valued at $1,951,325 using the latest closing price.

TADROS RAMY, the President, U.S. Business of Metlife Inc, sale 4,026 shares at $71.90 during a trade that took place back on Mar 13 ’24, which means that TADROS RAMY is holding 146,981 shares at $289,479 based on the most recent closing price.

Stock Fundamentals for MET

Current profitability levels for the company are sitting at:

  • 0.02 for the present operating margin
  • 1.0 for the gross margin

The net margin for Metlife Inc stands at 0.02. The total capital return value is set at 0.0. Equity return is now at value 5.53, with 0.23 for asset returns.

Based on Metlife Inc (MET), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at 0.73. The debt to equity ratio resting at 0.63. The interest coverage ratio of the stock is 0.99.

Currently, EBITDA for the company is 2.36 billion with net debt to EBITDA at -1.74. When we switch over and look at the enterprise to sales, we see a ratio of 0.72. The receivables turnover for the company is 2.29for trailing twelve months and the total asset turnover is 0.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.91.

Conclusion

In summary, Metlife Inc (MET) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts